World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
41
Citations
6135
World Ranking
7899
National Ranking
3396

Caryl E. Sortwell publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Caryl E. Sortwell sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 141 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Caryl E. Sortwell D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Caryl E. Sortwell sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 41 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Caryl E. Sortwell is affiliated with Michigan State University in the United States. Their research focuses primarily on the fields of Medicine and Neuroscience, with specific attention to Neurology and Cellular and Molecular Neuroscience. Other areas of study include Molecular Biology, Physiology, and Cognitive Neuroscience.

The main topics in Sortwell's work involve Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, nerve injury and regeneration, botulinum toxin and related neurological disorders, neuroscience and neuropharmacology research, Alzheimer's disease research and treatments, as well as nuclear receptors and signaling.

Recent publications by Sortwell include:

  • α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease, 2021, JCI Insight
  • Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits, 2020, Neurobiology of Disease
  • Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor, 2021, npj Parkinson s Disease
  • Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS, 2021, Journal of Neuroscience
  • Next-Generation Diamond Electrodes for Neurochemical Sensing: Challenges and Opportunities, 2021, Micromachines

Sortwell frequently publishes in prominent venues related to neuroscience and neurological diseases, including:

  • Neurobiology of Disease
  • npj Parkinson s Disease
  • Journal of Visualized Experiments
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Neuroscience

Collaborative work is common in Sortwell's career, with frequent coauthors including:

  • Joseph R. Patterson
  • Christopher J. Kemp
  • Kathy Steece-Collier
  • Kelvin C. Luk
  • Anna C. Stoll

Best Publications

  • Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

    Katrina L. Paumier;Kelvin C. Luk;Fredric P. Manfredsson;Nicholas M. Kanaan

  • Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.

    Nicole K. Polinski;Laura A. Volpicelli-Daley;Caryl E. Sortwell;Kelvin C. Luk

  • Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

    Susan O McGuire;Zao Dung Ling;Jack W Lipton;Caryl E Sortwell

  • A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.

    P.M. Carvey;Z.D. Ling;C.E. Sortwell;M.R. Pitzer

  • Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.

    Megan F Duffy;Timothy J Collier;Joseph R Patterson;Christopher J Kemp

  • TRANSFER OF HOST-DERIVED ALPHA SYNUCLEIN TO GRAFTED DOPAMINERGIC NEURONS IN RAT

    Jeffrey H. Kordower;Hemraj B. Dodiya;Adam M. Kordower;Brian Terpstra

  • Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism

    Timothy J. Collier;Jack Lipton;Brian F. Daley;Stephane Palfi

  • Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.

    Caryl E. Sortwell;Mark R. Pitzer;Timothy J. Collier

  • Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

    Jeffrey H. Kordower;Nicholas M. Kanaan;Yaping Chu;Rangasamy Suresh Babu

  • Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss

    A.L. Spieles-Engemann;M.M. Behbehani;T.J. Collier;S.L. Wohlgenant

  • Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex

    Anne L. Spieles-Engemann;Kathy Steece-Collier;Michael M. Behbehani;Timothy J. Collier

  • α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.

    Tracy A. Cole;Hien Zhao;Timothy J. Collier;Ivette Sandoval

  • Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats

    Eleonora Maries;Jeffrey H. Kordower;Yaping Chu;Timothy J. Collier

  • Therapeutic potential of nerve growth factors in Parkinson's disease.

    Timothy J. Collier;Caryl E. Sortwell

  • Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation.

    Timothy J. Collier;Caryl E. Sortwell;Brian F. Daley

  • Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity.

    Matthew J. Benskey;Rhyomi C. Sellnow;Ivette M. Sandoval;Ivette M. Sandoval;Caryl E. Sortwell;Caryl E. Sortwell

  • Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System

    Sara E. Gombash;Sara E. Gombash;Fredric P. Manfredsson;Christopher J. Kemp;Nathan C. Kuhn

  • Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.

    Joseph R. Patterson;Megan F. Duffy;Christopher J. Kemp;Jacob W. Howe

  • Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease

    Deanna M. Marchionini;Elin Lehrmann;Yaping Chu;Bin He

  • Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.

    Katherine E. Soderstrom;Jennifer A. O’Malley;Nathan D. Levine;Caryl E. Sortwell

  • Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells

    Mark R Pitzer;Caryl E Sortwell;Brian F Daley;Susan O McGuire

  • Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death.

    Caryl E. Sortwell;Brian F. Daley;Mark R. Pitzer;Susan O. McGuire

Frequent Co-Authors

Kathy Steece-Collier
Kathy Steece-Collier Michigan State University
Jack W. Lipton
Jack W. Lipton Michigan State University
Timothy J. Collier
Timothy J. Collier Michigan State University
Nicholas M. Kanaan
Nicholas M. Kanaan Michigan State University
Jeffrey H. Kordower
Jeffrey H. Kordower Arizona State University
Yaping Chu
Yaping Chu Rush University Medical Center
Omar M. A. El-Agnaf
Omar M. A. El-Agnaf Hamad bin Khalifa University
John R. Sladek
John R. Sladek University of Colorado Denver
Scott E. Counts
Scott E. Counts Michigan State University
Sheila M. Fleming
Sheila M. Fleming University of Cincinnati

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Caryl E. Sortwell

Trending Scientists

Recently Published Articles